JP2005508363A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508363A5 JP2005508363A5 JP2003539685A JP2003539685A JP2005508363A5 JP 2005508363 A5 JP2005508363 A5 JP 2005508363A5 JP 2003539685 A JP2003539685 A JP 2003539685A JP 2003539685 A JP2003539685 A JP 2003539685A JP 2005508363 A5 JP2005508363 A5 JP 2005508363A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- mood disorder
- composition
- group
- reuptake inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34008401P | 2001-10-29 | 2001-10-29 | |
| US60/340,084 | 2001-10-29 | ||
| US33788701P | 2001-11-02 | 2001-11-02 | |
| US60/337,887 | 2001-11-02 | ||
| PCT/US2002/034421 WO2003037342A1 (en) | 2001-10-29 | 2002-10-29 | Method of treating depression with delta receptor agonist compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508363A JP2005508363A (ja) | 2005-03-31 |
| JP2005508363A5 true JP2005508363A5 (enExample) | 2006-01-05 |
| JP4892654B2 JP4892654B2 (ja) | 2012-03-07 |
Family
ID=26990913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003539685A Expired - Fee Related JP4892654B2 (ja) | 2001-10-29 | 2002-10-29 | デルタレセプターアゴニスト化合物によるうつ病の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7030124B2 (enExample) |
| EP (1) | EP1450807B1 (enExample) |
| JP (1) | JP4892654B2 (enExample) |
| CN (1) | CN1596113B (enExample) |
| CA (1) | CA2464471C (enExample) |
| MX (1) | MXPA04004059A (enExample) |
| NO (1) | NO20042257L (enExample) |
| PL (1) | PL371297A1 (enExample) |
| RU (1) | RU2314809C2 (enExample) |
| TW (1) | TW200300089A (enExample) |
| WO (1) | WO2003037342A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60230869D1 (de) * | 2001-05-18 | 2009-03-05 | Astrazeneca Ab | 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen |
| US8476280B2 (en) * | 2002-05-09 | 2013-07-02 | Versi Group, Llc | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| SE0203300D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203303D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| US7314880B2 (en) * | 2003-01-02 | 2008-01-01 | Mount Cook Biosciences, Inc. | Cardioprotective delta opioid receptor agonists and methods of using same |
| BRPI0415165A (pt) | 2003-10-01 | 2007-01-09 | Adolor Corp | composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem |
| HRP20120343T1 (hr) * | 2004-08-02 | 2012-05-31 | Astrazeneca Ab | Derivati diarilmetil piperazina, njihovi pripravci i njihova uporaba |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| EP1874315A2 (en) * | 2005-04-14 | 2008-01-09 | Mount Cook Biosciences, Inc. | Compositions of novel opioid compounds and method of use thereof |
| WO2007027987A2 (en) | 2005-09-02 | 2007-03-08 | Mount Cook Biosciences, Inc. | Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| JP2011520956A (ja) * | 2008-05-20 | 2011-07-21 | アストラゼネカ・アクチエボラーグ | 不安大うつ病性障害を処置する方法 |
| CN103467460A (zh) * | 2013-09-23 | 2013-12-25 | 昆明理工大学 | 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用 |
| CN105646151B (zh) * | 2016-02-26 | 2018-06-29 | 山西大学 | 一种炔类化合物及其制备方法和该化合物的用途 |
| US10973815B2 (en) | 2016-03-31 | 2021-04-13 | Versi Group, Llc | Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| US20020052007A1 (en) | 1992-02-03 | 2002-05-02 | Chang Kwen Jen | Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| US5807858A (en) * | 1996-06-05 | 1998-09-15 | Delta Pharmaceutical, Inc. | Compositions and methods for reducing respiratory depression |
| US5681830A (en) * | 1992-02-03 | 1997-10-28 | Delta Pharmaceuticals, Inc. | Opioid compounds |
| US5985880A (en) * | 1996-06-05 | 1999-11-16 | Delta Pharmaceuticals | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| GB9202238D0 (en) * | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| US5574159A (en) * | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| HU221726B1 (hu) * | 1993-07-30 | 2002-12-28 | Ardent Pharmaceuticals Inc. | Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására |
| US6046200A (en) * | 1994-09-09 | 2000-04-04 | The United States Of America As Represented By The Secretary Of The Army | Compositions having neuroprotective and analgesic activity |
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| GB9709972D0 (en) * | 1997-05-19 | 1997-07-09 | Pfizer Ltd | Tetrazoles |
| GB9804734D0 (en) * | 1998-03-05 | 1998-04-29 | Pfizer Ltd | Compounds |
| EP0952154B1 (en) * | 1998-04-16 | 2004-08-18 | Pfizer Products Inc. | N-acyl and N-aroyl aralkyl amides |
| SE9904674D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904673D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904675D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| GB0017256D0 (en) * | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
| DE60230869D1 (de) | 2001-05-18 | 2009-03-05 | Astrazeneca Ab | 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen |
-
2002
- 2002-10-29 WO PCT/US2002/034421 patent/WO2003037342A1/en not_active Ceased
- 2002-10-29 TW TW091132060A patent/TW200300089A/zh unknown
- 2002-10-29 CN CN028237099A patent/CN1596113B/zh not_active Expired - Fee Related
- 2002-10-29 RU RU2004115748/14A patent/RU2314809C2/ru not_active IP Right Cessation
- 2002-10-29 JP JP2003539685A patent/JP4892654B2/ja not_active Expired - Fee Related
- 2002-10-29 EP EP02789294.2A patent/EP1450807B1/en not_active Expired - Lifetime
- 2002-10-29 US US10/282,411 patent/US7030124B2/en not_active Expired - Fee Related
- 2002-10-29 PL PL02371297A patent/PL371297A1/xx unknown
- 2002-10-29 CA CA2464471A patent/CA2464471C/en not_active Expired - Fee Related
- 2002-10-29 MX MXPA04004059A patent/MXPA04004059A/es unknown
-
2004
- 2004-06-01 NO NO20042257A patent/NO20042257L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508363A5 (enExample) | ||
| JP6931019B2 (ja) | 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター | |
| JP2003503450A5 (enExample) | ||
| RU2314809C2 (ru) | Способ лечения депрессии соединениями-агонистами дельта-рецепторов | |
| RU2010126063A (ru) | Производные 4-(2-амино-1-гидроксиэтил)фенола как агонисты в2 адренергического рецептора | |
| JP2002542287A (ja) | 医 薬 | |
| JP2007500238A5 (enExample) | ||
| JP2003506485A (ja) | 肥満治療を意図した薬剤の製造のためのモノアミンオキシダーゼ阻害剤の使用 | |
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| CN1711087A (zh) | 用于治疗眼新生血管性或水肿性紊乱和疾病的组蛋白脱乙酰酶抑制剂 | |
| JP2008536946A (ja) | うつ病の処置または予防のための新規の治療的組み合わせ | |
| BRPI0609952A2 (pt) | métodos para modular a função da bexiga | |
| KR20070083826A (ko) | 우울증을 위한 부가 요법 | |
| JP7592007B2 (ja) | 睡眠時無呼吸の治療のためのα２‐アドレナリン受容体サブタイプＣ （ＡＬＰＨＡ‐２Ｃ）拮抗薬 | |
| JP3096306B2 (ja) | 新規な治療方法 | |
| US6849654B2 (en) | 5-methoxy-carbonylamino-N-acetyltryptamine compounds and derivates thereof | |
| JP2006516643A5 (enExample) | ||
| JP2018203774A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| JP2006510632A5 (enExample) | ||
| JP2010514682A5 (enExample) | ||
| JP2002541190A (ja) | 気分障害治療用医薬を製造するためのオサネタントの使用 | |
| JP2011088919A (ja) | アゴメラチンとノルアドレナリン再取り込み阻害剤との新たな組み合わせ、及びそれを含有している医薬組成物 | |
| JP2004262812A (ja) | 眼圧低下剤 | |
| JP2002524509A (ja) | 新規組成物 | |
| CA3139357A1 (en) | Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea |